Pluripotent Stem Cells: Induction and Self-renewal

Overview

Journal Philos Trans R Soc Lond B Biol Sci

Specialty Biology

Date 2018 May 23

PMID 29786549

Citations 18

Authors

R Abu-Dawud

N Graffmann

S Ferber

W Wruck

J Adjaye

Affiliations

Soon will be listed here.

Abstract

Pluripotent stem cells (PSCs) lie at the heart of modern regenerative medicine due to their properties of unlimited self-renewal and their ability to differentiate into cell types representative of the three embryonic germ layers-mesoderm, ectoderm and endoderm. The derivation of induced PSCs bypasses ethical concerns associated with the use of human embryonic stem cells and also enables personalized cell-based therapies. To exploit their regenerative potential, it is essential to have a firm understanding of the molecular processes associated with their induction from somatic cells. This understanding serves two purposes: first, to enable efficient, reliable and cost-effective production of excellent quality induced PSCs and, second, to enable the derivation of safe, good manufacturing practice-grade transplantable donor cells. Here, we review the reprogramming process of somatic cells into induced PSCs and associated mechanisms with emphasis on self-renewal, epigenetic control, mitochondrial bioenergetics, sub-states of pluripotency, naive ground state, naive and primed. A meta-analysis identified genes expressed exclusively in the inner cell mass and in the naive but not in the primed pluripotent state. We propose these as additional biomarkers defining naive PSCs.This article is part of the theme issue 'Designer human tissue: coming to a lab near you'.

Citing Articles

Mesenchymal Stem Cells and Tissue Bioengineering Applications in Sheep as Ideal Model.

Muniz T, Rossi M, de Vasconcelos Machado V, Alves A Stem Cells Int. 2024; 2024:5176251.

PMID: 39465229 PMC: 11511598. DOI: 10.1155/2024/5176251.

Photocuring 3D printing technology as an advanced tool for promoting angiogenesis in hypoxia-related diseases.

Lee S, Phuc H, Um S, Mongrain R, Yoon J, Bhang S J Tissue Eng. 2024; 15:20417314241282476.

PMID: 39345255 PMC: 11437565. DOI: 10.1177/20417314241282476.

An Overview of Multiple Sclerosis In Vitro Models.

Czpakowska J, Kaluza M, Szpakowski P, Glabinski A Int J Mol Sci. 2024; 25(14).

PMID: 39063001 PMC: 11276743. DOI: 10.3390/ijms25147759.

To Repair a Broken Heart: Stem Cells in Ischemic Heart Disease.

Stougiannou T, Christodoulou K, Dimarakis I, Mikroulis D, Karangelis D Curr Issues Mol Biol. 2024; 46(3):2181-2208.

PMID: 38534757 PMC: 10969169. DOI: 10.3390/cimb46030141.

Free Bilirubin Induces Neuro-Inflammation in an Induced Pluripotent Stem Cell-Derived Cortical Organoid Model of Crigler-Najjar Syndrome.

Pranty A, Wruck W, Adjaye J Cells. 2023; 12(18).

PMID: 37759499 PMC: 10527749. DOI: 10.3390/cells12182277.

References

Ware C, Nelson A, Mecham B, Hesson J, Zhou W, Jonlin E . Derivation of naive human embryonic stem cells. Proc Natl Acad Sci U S A. 2014; 111(12):4484-9. PMC: 3970494. DOI: 10.1073/pnas.1319738111. View

Blanchard J, Xie J, El-Mecharrafie N, Gross S, Lee S, Lerner R . Replacing reprogramming factors with antibodies selected from combinatorial antibody libraries. Nat Biotechnol. 2017; 35(10):960-968. DOI: 10.1038/nbt.3963. View

Tada M, Tada T, Lefebvre L, Barton S, Surani M . Embryonic germ cells induce epigenetic reprogramming of somatic nucleus in hybrid cells. EMBO J. 1997; 16(21):6510-20. PMC: 1170256. DOI: 10.1093/emboj/16.21.6510. View

Stadtfeld M, Nagaya M, Utikal J, Weir G, Hochedlinger K . Induced pluripotent stem cells generated without viral integration. Science. 2008; 322(5903):945-9. PMC: 3987909. DOI: 10.1126/science.1162494. View

Staerk J, Lyssiotis C, Medeiro L, Bollong M, Foreman R, Zhu S . Pan-Src family kinase inhibitors replace Sox2 during the direct reprogramming of somatic cells. Angew Chem Int Ed Engl. 2011; 50(25):5734-6. PMC: 3409461. DOI: 10.1002/anie.201101042. View

Chen G, Hou Z, Gulbranson D, Thomson J . Actin-myosin contractility is responsible for the reduced viability of dissociated human embryonic stem cells. Cell Stem Cell. 2010; 7(2):240-8. PMC: 2916864. DOI: 10.1016/j.stem.2010.06.017. View

Dai P, Harada Y, Takamatsu T . Highly efficient direct conversion of human fibroblasts to neuronal cells by chemical compounds. J Clin Biochem Nutr. 2015; 56(3):166-70. PMC: 4454078. DOI: 10.3164/jcbn.15-39. View

Kattman S, Witty A, Gagliardi M, Dubois N, Niapour M, Hotta A . Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. Cell Stem Cell. 2011; 8(2):228-40. DOI: 10.1016/j.stem.2010.12.008. View

Anokye-Danso F, Trivedi C, Juhr D, Gupta M, Cui Z, Tian Y . Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. Cell Stem Cell. 2011; 8(4):376-88. PMC: 3090650. DOI: 10.1016/j.stem.2011.03.001. View

10.

Bohndorf M, Ncube A, Spitzhorn L, Enczmann J, Wruck W, Adjaye J . Derivation and characterization of integration-free iPSC line ISRM-UM51 derived from SIX2-positive renal cells isolated from urine of an African male expressing the CYP2D6 *4/*17 variant which confers intermediate drug metabolizing activity. Stem Cell Res. 2017; 25:18-21. DOI: 10.1016/j.scr.2017.10.004. View

11.

Folmes C, Nelson T, Martinez-Fernandez A, Arrell D, Lindor J, Dzeja P . Somatic oxidative bioenergetics transitions into pluripotency-dependent glycolysis to facilitate nuclear reprogramming. Cell Metab. 2011; 14(2):264-71. PMC: 3156138. DOI: 10.1016/j.cmet.2011.06.011. View

12.

Mandai M, Watanabe A, Kurimoto Y, Hirami Y, Morinaga C, Daimon T . Autologous Induced Stem-Cell-Derived Retinal Cells for Macular Degeneration. N Engl J Med. 2017; 376(11):1038-1046. DOI: 10.1056/NEJMoa1608368. View

13.

Park G, Yoon B, Kim Y, Choi S, Moon J, Kwon S . Conversion of mouse fibroblasts into cardiomyocyte-like cells using small molecule treatments. Biomaterials. 2015; 54:201-12. DOI: 10.1016/j.biomaterials.2015.02.029. View

14.

Boraas L, Guidry J, Pineda E, Ahsan T . Cytoskeletal Expression and Remodeling in Pluripotent Stem Cells. PLoS One. 2016; 11(1):e0145084. PMC: 4714815. DOI: 10.1371/journal.pone.0145084. View

15.

Wang W, Yang J, Liu H, Lu D, Chen X, Zenonos Z . Rapid and efficient reprogramming of somatic cells to induced pluripotent stem cells by retinoic acid receptor gamma and liver receptor homolog 1. Proc Natl Acad Sci U S A. 2011; 108(45):18283-8. PMC: 3215025. DOI: 10.1073/pnas.1100893108. View

16.

Li X, Zuo X, Jing J, Ma Y, Wang J, Liu D . Small-Molecule-Driven Direct Reprogramming of Mouse Fibroblasts into Functional Neurons. Cell Stem Cell. 2015; 17(2):195-203. DOI: 10.1016/j.stem.2015.06.003. View

17.

Wilmut I, Schnieke A, McWhir J, Kind A, Campbell K . Viable offspring derived from fetal and adult mammalian cells. Nature. 1997; 385(6619):810-3. DOI: 10.1038/385810a0. View

18.

Si-Tayeb K, Noto F, Sepac A, Sedlic F, Bosnjak Z, Lough J . Generation of human induced pluripotent stem cells by simple transient transfection of plasmid DNA encoding reprogramming factors. BMC Dev Biol. 2010; 10:81. PMC: 2923111. DOI: 10.1186/1471-213X-10-81. View

19.

Hoelder S, Clarke P, Workman P . Discovery of small molecule cancer drugs: successes, challenges and opportunities. Mol Oncol. 2012; 6(2):155-76. PMC: 3476506. DOI: 10.1016/j.molonc.2012.02.004. View

20.

Kim M, Kino-Oka M . Maintenance of undifferentiated state of human induced pluripotent stem cells through cytoskeleton-driven force acting to secreted fibronectin on a dendrimer-immobilized surface. J Biosci Bioeng. 2014; 118(6):716-22. DOI: 10.1016/j.jbiosc.2014.05.011. View